Updated living WHO guideline on drugs for Covid-19, WHO ( updated 13th January 2023)

Update contains new data supporting existing recommendations. Nirmatrelvir/ritonavir is considered also an option for pregnant and breastfeeding women with non-severe illness. Further evidence supports strong recommendations against use of sotrovimab and casirivimab-imdevimab.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news